Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Chie-Schin Shih"'
Autor:
Kohei Shitara, Kei Muro, Razvan Cristescu, Michael Nebozhyn, Andrey Loboda, Hyun Cheol Chung, Wasat Mansoor, Mustafa Ozguroglu, Mario Mandala, Maria Di Bartolomeo, Christian Caglevic, Julie Kobie, Min-Hee Ryu, Z Alexander Cao, Tomasz Olesinski, Eray Goekkurt, Raymond S McDermott, Zev A Wainberg, Chie-Schin Shih
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 6 (2023)
Background In the randomized, controlled, phase III KEYNOTE-061 trial, second-line pembrolizumab did not significantly prolong overall survival (OS) versus paclitaxel in patients with PD-L1-positive (combined positive score ≥1) advanced gastric/gas
Externí odkaz:
https://doaj.org/article/47cdd46fe09d4f619548677a08c6eb63
Autor:
Zev A. Wainberg, Jipan Xie, Adriana Valderrama, Lei Yin, Shujing Zhang, Chie-Schin Shih, Pooja Bhagia, Qianqian Gu, Kohei Shitara, Yelena Y. Janjigian, Josep Tabernero
Publikováno v:
Clinical Cancer Research. 29:1360-1367
Purpose: This study assessed the trial-level association between event-free survival (EFS) and overall survival (OS) in gastric or gastroesophageal junction (GEJ) adenocarcinoma in the neoadjuvant ± adjuvant settings. Experimental Design: A systemat
Autor:
Allison L Bartlett, Adam Lane, Brooklyn Chaney, Nancy Yanez Escorza, Katie Black, Anne Cochrane, Jane Minturn, Ute Bartels, Kathy Warren, Jordan Hansford, David Ziegler, Blanca Diez, Stewart Goldman, Roger Packer, Mark Kieran, Mariko DeWire-Schottmiller, Craig Erker, Michelle Monje-Deisseroth, Lars Wagner, Carl Koschmann, Kathleen Dorris, Chie-Schin Shih, Tim Hassall, Yvan Samson, Paul Fisher, Stacie S Wang, Karen Tsui, Gustavo Sevlever, Xiaoting Zhu, Phillip Dexheimer, Anthony Asher, Christine Fuller, Rachid Drissi, Blaise Jones, James Leach, Maryam Fouladi
Publikováno v:
Neuro Oncol
Background Children ≤36 months with diffuse intrinsic pontine glioma (DIPG) have increased long-term survival (LTS, overall survival (OS) ≥24 months). Understanding distinguishing characteristics in this population is critical to improving outcom
Autor:
Josep Tabernero, Yelena Y. Janjigian, Kohei Shitara, Qianqian Gu, Pooja Bhagia, Chie-Schin Shih, Shujing Zhang, Lei Yin, Adriana Valderrama, Jipan Xie, Zev A. Wainberg
Summary of main study characteristics of the neoadjvuant RCTs included in the analyses
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18879835284d6aaa68ba21c92f528e8d
https://doi.org/10.1158/1078-0432.22494828
https://doi.org/10.1158/1078-0432.22494828
Autor:
Josep Tabernero, Yelena Y. Janjigian, Kohei Shitara, Qianqian Gu, Pooja Bhagia, Chie-Schin Shih, Shujing Zhang, Lei Yin, Adriana Valderrama, Jipan Xie, Zev A. Wainberg
Purpose:This study assessed the trial-level association between event-free survival (EFS) and overall survival (OS) in gastric or gastroesophageal junction (GEJ) adenocarcinoma in the neoadjuvant ± adjuvant settings.Experimental Design:A systematic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f26e14550b68bb8ee8095a30a42e51f5
https://doi.org/10.1158/1078-0432.c.6533170.v1
https://doi.org/10.1158/1078-0432.c.6533170.v1
Autor:
Craig Erker, Adam Lane, Brooklyn Chaney, Sarah Leary, Jane E Minturn, Ute Bartels, Roger J Packer, Kathleen Dorris, Nicholas G Gottardo, Katherine E Warren, Alberto Broniscer, Mark W Kieran, Xiaoting Zhu, Peter White, Phillip J Dexheimer, Katie Black, Anthony Asher, Mariko DeWire, Jordan R Hansford, Sridharan Gururangan, Javad Nazarian, David S Ziegler, Eric Sandler, Allison Bartlett, Stewart Goldman, Chie-Schin Shih, Tim Hassall, Hetal Dholaria, Pratiti Bandopadhayay, Yvan Samson, Michelle Monje, Paul G Fisher, Andrew Dodgshun, Sarah Parkin, Murali Chintagumpala, Karen Tsui, David Gass, Valerie Larouche, Emmett Broxson, Mercedes Garcia Lombardi, Stacie Shiqi Wang, Jie Ma, Cynthia Hawkins, Dima Hamideh, Lars Wagner, Carl Koschmann, Christine Fuller, Rachid Drissi, Blaise V Jones, James Leach, Maryam Fouladi
Publikováno v:
Neuro Oncol
BackgroundDiffuse intrinsic pontine gliomas (DIPG) generally occur in young school-age children, although can occur in adolescents and young adults. The purpose of this study was to describe clinical, radiological, pathologic, and molecular character
Autor:
Markus Moehler, Chie Schin Shih, Jaafar Bennouna, Lin Shen, Anjali Desai, Xiaolong Fu, Manish A. Shah, Antoine Adenis, Pooja Bhagia, Sonal Bordia, Peter C. Enzinger, Harvey J. Mamon, Ken Kato, Toshihiko Doi, Byoung Chul Cho
Publikováno v:
Future Oncology
Despite curative-intent treatment, most patients with locally advanced esophageal cancer will experience disease recurrence or locoregional progression, highlighting the need for new therapies. Current guidelines recommend definitive chemoradiotherap
Autor:
Patricio Eduardo Yanez, Irit Ben-Aharon, Carlos Rojas, Daniel Acosta Eyzaguirre, Ayala Hubert, Hernan Araya, Deirdre Jill Cohen, Li-Yuan Bai, François Ghiringhelli, Lucjan Wyrwicz, Yelena Y. Janjigian, Josep Tabernero, Eric Van Cutsem, Shukui Qin, Jianming Xu, Anran Wang, Mary Gwen Miller, Chie-Schin Shih, Pooja Bhagia, Kohei Shitara
Publikováno v:
Journal of Clinical Oncology. 41:411-411
411 Background: LEAP-015 (NCT04662710) is a randomized, open-label, 2-part, phase 3 study of the safety and efficacy of lenvatinib + pembrolizumab + chemotherapy as a first-line treatment for advanced/metastatic gastroesophageal adenocarcinoma. We re
Autor:
Yung-Jue Bang, Eric Van Cutsem, Zev A. Wainberg, Weijing Sun, Mustafa Ozguroglu, Kohei Shitara, Kei Muro, Eray Goekkurt, Mayur Amonkar, Al B. Benson, Josephine M. Norquist, Chie Schin Shih, Charles S. Fuchs, Hyun Cheol Chung, Maria Alsina, X. Chen
Publikováno v:
Gastric Cancer
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, vol 24, iss 6
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, vol 24, iss 6
BackgroundIn the primary analysis population (i.e., PD-L1 combined positive score [CPS] ≥ 1) of the phase 3 KEYNOTE-061 study (NCT02370498), pembrolizumab did not significantly prolong overall survival or progression-free survival. Pembrolizumab ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::867148dcb0d7a1d3ab94dc2664041d4d
https://lirias.kuleuven.be/handle/123456789/680658
https://lirias.kuleuven.be/handle/123456789/680658
Autor:
Hyun Cheol Chung, Yoon‐Koo Kang, Zhendong Chen, Yuxian Bai, Wan Zamaniah Wan Ishak, Byoung Yong Shim, Young Lee Park, Dong‐Hoe Koo, Jianwei Lu, Jianming Xu, Hong Jae Chon, Li‐Yuan Bai, Shan Zeng, Ying Yuan, Yen‐Yang Chen, Kangsheng Gu, Wen Yan Zhong, Shu Kuang, Chie‐Schin Shih, Shu‐Kui Qin
Publikováno v:
Cancer. 128(5)
KEYNOTE-063 (NCT03019588) investigated pembrolizumab versus paclitaxel as second-line therapy in Asian patients with advanced programmed death ligand 1 (PD-L1)-positive (combined positive score ≥1) gastric/gastroesophageal junction (GEJ) cancer.Thi